Consultancy
  • January 1, 2022 - December 31, 2022
    Preclinical Development of Cancer Stem Cell (CSC) Inhibitor

    Godavari Biorefineries Ltd., Mumbai

    Total Outlay Rs.7,50,000
  • April 1, 2022 – March 30, 2023
    Novel Products of Commercial Importance

    Panopharm

    Total Outlay: Rs.3,60,000
  • January 1, 2021 - December 31, 2021
    Preclinical Development of Cancer Stem Cell (CSC) Inhibitor

    Godavari Biorefineries Ltd., Mumbai

    Total Outlay: Rs. 7,50,000
  • January 1, 2020 - December 31, 2020
    Preclinical Development of Cancer Stem Cell

    Godavari Biorefineries Ltd., Mumbai

    Total Outlay: Rs.7,50,000
  • January 1, 2020 – June 30, 2020
    Advent ChemBio Pvt. Ltd., Mumbai
    Total Outlay: Rs.45,000
  • January 1, 2019 - September 30, 2019
    Development of Novel Anti-Cancer Stem Cell (CSC) Therapeutics

    Godavari Biorefineries Ltd., Mumbai

    Total Outlay: Rs.6,00,000
  • January 1, 2018 - December 31, 2018
    Development of Novel Anti-Cancer Stem Cell (CSC) Therapeutics

    Godavari Biorefineries Ltd., Mumbai

    Total Outlay: Rs.4,00,000
  • December 15, 2016 - December 31, 2017
    Development of Novel Anti-Cancer Stem Cell (CSC) Therapeutics

    Godavari Biorefineries Ltd., Mumbai

    Total Outlay: Rs.4,00,000
  • (December 15, 2015 - December 14, 2016
    Development of Novel Anti-Cancer Stem Cell (CSC) Therapeutics

    Godavari Biorefineries Ltd., Mumbai

    Total Outlay: Rs.4,00,000
  • October 1, 2014 - September 30, 2015
    Computer-Aided Molecular Design of Novel Anti-Cancer Stem Cell (CSC) Therapeutics

    Godavari Biorefineries Ltd., Mumbai

    Total Outlay: Rs.2,00,000